PCM
MGNX icon

Penserra Capital Management’s MacroGenics MGNX Stock Holding History

Penserra Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,400
Closed -$29K – 1473
2021
Q3 		$29K Buy
1,400
+35
+3% +$843 ﹤0.01% 1189
2021
Q2 		$36K Buy
1,365
+95
+7% +$2.78K ﹤0.01% 1069
2021
Q1 		$40K Sell
1,270
-40
-3% -$971 ﹤0.01% 849
2020
Q4 		$29K Buy
1,310
+846
+182% +$19.5K ﹤0.01% 787
2020
Q3 		$11K Buy
+464
New +$12.7K ﹤0.01% 806

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Penserra Capital Management's MGNX Position: Q4 2021 in Review

Penserra Capital Management sold out of MacroGenics (MGNX) in Q4 2021, closing a stake of 1,400 shares — an estimated $29K sold.

Penserra Capital Management first reported a position in MGNX in Q3 2020 and held it in 5 quarters. The position peaked at $40K in Q1 2021. 156 funds tracked by Wall St. Rank hold MGNX as of Q4 2021.

  • Penserra Capital Management reported no remaining MacroGenics position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 1,400 MacroGenics shares in Q4 2021, an estimated $29K.
  • Penserra Capital Management first reported a position in MacroGenics in Q3 2020 and held it in 5 quarters.
  • Penserra Capital Management's MacroGenics position peaked at $40K in Q1 2021.
  • 156 funds tracked by Wall St. Rank held MacroGenics as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.